Fig. S1. Analysis of the CYP116B1 heme cofactor properties by resonance Raman spectroscopy

Fig. S2. Vernolate and EPTC LC-MS controls

Fig. S3. Product analysis of CYP116B1 EPTC turnover by LC-MS

Fig. S4. Amino acid alignment of the structurally resolved Burkholderia cepacia phthalate dioxygenase reductase (B. cepacia PDOR) and the reductase domain of Cupriavidus metallidurans CYP116B1 (CYP116B1-RED). Amino acid alignment of the reductase domain of CYP116B1 (RED) with the structurally resolved Burkholderia cepacia phthalate dioxygenase reductase (B. cepacia PDOR) and key amino acids involved in FMN binding and pyridine cofactor binding/specificity

Please note: As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer-reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

FEBS_8543_sm_FigS1-S4.zip533KSupporting info item

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.